1.
Why Have Antioxidants Failed in Clinical Trials?
by Steinhubl, Steven R., MD
The American journal of cardiology, 2008, Vol.101 (10), p.S14-S19

2.
Safety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 Randomized Trials
by Jones, Peter H
The American journal of cardiology, 2016-12-15, Vol.118 (12), p.1805-1811

3.
Safety Considerations with Fibrate Therapy
by Davidson, Michael H., MD
The American journal of cardiology, 2007, Vol.99 (6), p.S3-S18

4.
Meta-Analysis of Ten Trials on the Effectiveness of the Radial Versus the Femoral Approach in Primary Percutaneous Coronary Intervention
by Joyal, Dominique, MD
The American journal of cardiology, 2012, Vol.109 (6), p.813-818

5.
Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus
by Navarese, Eliano Pio, MD, PhD
The American journal of cardiology, 2013, Vol.111 (8), p.1123-1130

6.
Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease
by Micha, Renata, RD, PhD
The American journal of cardiology, 2011, Vol.108 (9), p.1362-1370

7.
Review of Major Registries and Clinical Trials of Late Outcomes After Transcatheter Aortic Valve Replacement
by Arora, Sameer, MD
The American journal of cardiology, 2017, Vol.120 (2), p.331-336

8.
Impact of Funding Source on Clinical Trial Results Including Cardiovascular Outcome Trials
by Riaz, Haris, MD
The American journal of cardiology, 2015, Vol.116 (12), p.1944-1947

9.
Meta-Analysis of Perceived Stress and Its Association With Incident Coronary Heart Disease
by Richardson, Safiya, MD
The American journal of cardiology, 2012, Vol.110 (12), p.1711-1716

10.
Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)
by Ballantyne, Christie M., MD
The American journal of cardiology, 2012, Vol.110 (7), p.984-992

11.
Statin and the Risk of Renal-Related Serious Adverse Events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and Other Placebo-Controlled Trials
by Bangalore, Sripal, MD, MHA
The American journal of cardiology, 2014, Vol.113 (12), p.2018-2020

12.
Trends in Utilization of Surrogate Endpoints in Contemporary Cardiovascular Clinical Trials
by Patel, Ravi B., MD
The American journal of cardiology, 2015, Vol.117 (11), p.1845-1850

13.
Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week stud...
by Bays, Harold E., MD
The American journal of cardiology, 2011, Vol.108 (5), p.682-690

14.
Meta-Analysis of Aerobic Interval Training on Exercise Capacity and Systolic Function in Patients With Heart Failure and Reduced Ejection Fractions
by Haykowsky, Mark J., PhD
The American journal of cardiology, 2013, Vol.111 (10), p.1466-1469

15.
Recent National Cholesterol Education Program Adult Treatment Panel III Update: Adjustments and Options
by Stone, Neil J
The American journal of cardiology, 2005, Vol.96 (4), p.53-59

16.
Conflicts of Interest and Outcomes of Cardiovascular Trials
by Riaz, Haris, MD
The American journal of cardiology, 2016, Vol.117 (5), p.858-860

17.
Effect of Alirocumab, a Monoclonal Proprotein Convertase Subtilisin/Kexin 9 Antibody, on Lipoprotein(a) Concentrations (a Pooled Analysis of 150 mg Every Two Weeks Dosing from Phas...
by Gaudet, Daniel, MD, PhD
The American journal of cardiology, 2014, Vol.114 (5), p.711-715

18.
Recent Clinical Studies of the Effects of Lipid-Modifying Therapies
by Gotto, Antonio M., MD, DPhil
The American journal of cardiology, 2012, Vol.110 (1), p.15A-26A

19.
One-Year Consumption of a Grape Nutraceutical Containing Resveratrol Improves the Inflammatory and Fibrinolytic Status of Patients in Primary Prevention of Cardiovascular Disease
by Tomé-Carneiro, João, MSc
The American journal of cardiology, 2012, Vol.110 (3), p.356-363

20.
Persistence of123I- m IBG Prognostic Capability in Relation to Medical Therapy in Heart Failure (from the ADMIRE-HF Trial)
by Ileana L Piña
The American journal of cardiology, 2017-02-01, Vol.119 (3), p.434
